Oxford Clinical Neuropsychology Services - Accounts to registrar (filleted) - small 18.2

Oxford Clinical Neuropsychology Services - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.3.1.65 08803999 director 1.4.17 31.3.18 31.3.18 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure088039992017-03-31088039992018-03-31088039992017-04-012018-03-31088039992016-03-31088039992016-04-012017-03-31088039992017-03-3108803999ns15:EnglandWales2017-04-012018-03-3108803999ns14:PoundSterling2017-04-012018-03-3108803999ns10:Director12017-04-012018-03-3108803999ns10:PrivateLimitedCompanyLtd2017-04-012018-03-3108803999ns10:SmallEntities2017-04-012018-03-3108803999ns10:AuditExempt-NoAccountantsReport2017-04-012018-03-3108803999ns10:SmallCompaniesRegimeForDirectorsReport2017-04-012018-03-3108803999ns10:SmallCompaniesRegimeForAccounts2017-04-012018-03-3108803999ns10:FullAccounts2017-04-012018-03-3108803999ns10:CompanySecretary12017-04-012018-03-3108803999ns10:RegisteredOffice2017-04-012018-03-3108803999ns5:CurrentFinancialInstruments2018-03-3108803999ns5:CurrentFinancialInstruments2017-03-3108803999ns5:ShareCapital2018-03-3108803999ns5:ShareCapital2017-03-3108803999ns5:RetainedEarningsAccumulatedLosses2018-03-3108803999ns5:RetainedEarningsAccumulatedLosses2017-03-3108803999ns5:PlantMachinery2017-04-012018-03-3108803999ns5:ComputerEquipment2017-04-012018-03-3108803999ns5:PlantMachinery2017-03-3108803999ns5:ComputerEquipment2017-03-3108803999ns5:PlantMachinery2018-03-3108803999ns5:ComputerEquipment2018-03-3108803999ns5:PlantMachinery2017-03-3108803999ns5:ComputerEquipment2017-03-3108803999ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-03-3108803999ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-03-31


REGISTERED NUMBER: 08803999 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2018

for

Oxford Clinical Neuropsychology Services
Limited

Oxford Clinical Neuropsychology Services
Limited (Registered number: 08803999)

Contents of the Financial Statements
for the Year Ended 31 March 2018










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Oxford Clinical Neuropsychology Services
Limited

Company Information
for the Year Ended 31 March 2018







DIRECTOR: Dr. R B Scott





SECRETARY: Mill House Secretarial Limited





REGISTERED OFFICE: The Mill House
Boundary Road
Loudwater
High Wycombe
Bucks.
HP10 9QN





REGISTERED NUMBER: 08803999 (England and Wales)





ACCOUNTANTS: The Fish Partnership
The Mill House
Boundary Road
Loudwater
High Wycombe
Bucks.
HP10 9QN

Oxford Clinical Neuropsychology Services
Limited (Registered number: 08803999)

Balance Sheet
31 March 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 19,057 19,802

CURRENT ASSETS
Debtors 5 341,768 288,651
Cash at bank 75,791 18,787
417,559 307,438
CREDITORS
Amounts falling due within one year 6 60,895 66,617
NET CURRENT ASSETS 356,664 240,821
TOTAL ASSETS LESS CURRENT
LIABILITIES

375,721

260,623

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 375,719 260,621
SHAREHOLDERS' FUNDS 375,721 260,623

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2018 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at
the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director on 22 November 2018 and were signed by:





Dr. R B Scott - Director


Oxford Clinical Neuropsychology Services
Limited (Registered number: 08803999)

Notes to the Financial Statements
for the Year Ended 31 March 2018


1. STATUTORY INFORMATION

Oxford Clinical Neuropsychology Services Limited is a private company, limited by shares , registered
in England and Wales. The company's registered number and registered office address can be found
on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts,
rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 10% on cost
Computer equipment - Straight line over 3 years

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss
Account, except to the extent that it relates to items recognised in other comprehensive income or
directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been
enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at
the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is measured
using tax rates and laws that have been enacted or substantively enacted by the year end and that are
expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable
that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the
company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2017 - 1 ) .

Oxford Clinical Neuropsychology Services
Limited (Registered number: 08803999)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2018


4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 April 2017 20,000 7,010 27,010
Additions - 5,388 5,388
At 31 March 2018 20,000 12,398 32,398
DEPRECIATION
At 1 April 2017 4,000 3,208 7,208
Charge for year 2,000 4,133 6,133
At 31 March 2018 6,000 7,341 13,341
NET BOOK VALUE
At 31 March 2018 14,000 5,057 19,057
At 31 March 2017 16,000 3,802 19,802

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade debtors 86,564 95,696
Other debtors 255,204 192,955
341,768 288,651

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Taxation and social security 57,741 64,117
Other creditors 3,154 2,500
60,895 66,617

7. RELATED PARTY DISCLOSURES

During the period, total dividends of £73,000 (2017: £75,000) were paid to the director.

At 31 March 2018 the company was owed £207,182 (2017 £144,933) from the director in respect of an
overdrawn director's loan account.

8. ULTIMATE CONTROLLING PARTY

The controlling party of the company throughout the year was Dr. R B Scott, by virtue of him being the
sole director and shareholder.